|
2025
|
Invention
|
Method for determining the age of red blood cells. Glycated Hb was measured in reticulocytes (RNA... |
|
2024
|
Invention
|
Cd5 targeting antibodies with depleting and t or b-cell activation effects. The CD5 antigen (or "... |
|
|
Invention
|
Methods of prognosis and treatment of patients suffering from cancer. Lung fibroblast play an imp... |
|
|
Invention
|
Inhibitor of the transcription factor ap-1 for use in the treatment of age-related diseases. The ... |
|
|
Invention
|
Langerhans cells targeting hiv-1 vaccines. Developing an effective HIV-1 vaccine is contingent on... |
|
|
Invention
|
Anti-tuberculosis vaccine targeting selected mycobacterium tuberculosis protective antigens to de... |
|
|
Invention
|
Use of the recombinant fibrinogen-like domain of angiopoietin-like 4 for treating adverse post-is... |
|
2023
|
Invention
|
Method for generating a deployment weighted multigraph of connected objects and method for genera... |
|
|
Invention
|
Method for determining the relative age of red blood cells. in vitroin vitro determination of the... |
|
|
Invention
|
Cd81 as a biomarker and biotarget in t-cell malignancies. The present study of the regulatory T p... |
|
|
Invention
|
Method for hepatocellular carcinoma risk stratification. The invention relates to a method for he... |
|
|
Invention
|
Dc-targeting vaccine against nipah virus infection. Nipah virus (NiV) is a recently emergent, hig... |
|
|
Invention
|
New method to treat and diagnose peripheral t-cell lymphoma (ptcl). The present invention relates... |
|
|
Invention
|
Lrrc33 as a biomarker and biotarget in cutaneous t-cell lymphomas. The present study of the regul... |
|
|
Invention
|
Garp as a biomarker and biotarget in t-cell malignancies. The present study of the regulatory T p... |
|
|
Invention
|
Methods for the diagnosis and treatment of acute lymphoblastic leukemia. The present invention re... |
|
|
Invention
|
Specialised pro-resolution lipid mediator (spm) compounds for use in the treatment of cystic fibr... |
|
|
Invention
|
Carbon monoxide-releasing molecule (corm) or composition thereof for use in the treatment or the ... |
|
|
Invention
|
Batteries provided with a thermal management system comprising phase-change materials.
A battery... |
|
|
Invention
|
Batteries provided with a thermal management system comprising phase-change materials. The invent... |
|
|
Invention
|
Methods for the diagnosis and treatment of t cell-lymphomas. T-cell lymphomas are a heterogeneous... |
|
|
Invention
|
Methods for the diagnosis and treatment of t-cell malignancies.
T-cell malignancies are a broad,... |
|
|
Invention
|
Methods for the diagnosis and treatment of t-cell malignancies. T-cell malignancies are a broad, ... |
|
|
Invention
|
Anti-cd160 transmembrane isoform antibodies.
The present invention relates to antibodies and ant... |
|
|
Invention
|
Anti-cd160 transmembrane isoform antibodies. The present invention relates to antibodies and anti... |
|
2022
|
Invention
|
Method for delithiating at least one lithium and transition-metal nitride.
A method for delithia... |
|
|
Invention
|
Method for delithiating at least one lithium and transition-metal nitride. The invention relates ... |
|
|
Invention
|
Inhibitors of abnormal phosphorylation and tau protein aggregation.
The present disclosure relat... |
|
|
Invention
|
Inhibitors of abnormal phosphorylation and tau protein aggregation. The present disclosure relate... |
|
|
Invention
|
Universal sarbecovirus vaccines.
Sarbecoviruses (lineage B of genus Betacoronavirus) have caused... |
|
|
Invention
|
Universal sarbecovirus vaccines. Sarbecoviruses (lineage B of genus Betacoronavirus) have caused ... |
|
|
Invention
|
Method for studying the behaviour of a cell sample.
A method for studying the behaviour of a cel... |
|
|
Invention
|
Method for studying the behaviour of a cell sample. The invention relates to a method for studyin... |
|
|
Invention
|
Method for quantifying ahsp protein and its use for prognosing a haemoglobin-related disorder.
T... |
|
|
Invention
|
Methods for the diagnosis and treatment of t cell-lymphomas.
T-cell lymphomas are a heterogeneou... |
|
|
Invention
|
Chlamydia trachomatis antigenic polypeptides and uses thereof for vaccine purposes.
Chlamydiae a... |
|
2021
|
Invention
|
Chlamydia vaccine based on targeting momp vs4 antigen to antigen presenting cells.
Chlamydiae ar... |
|
|
Invention
|
Anti-cd25 antibodies.
Novel anti-human CD25 antibodies and their use for treating cancer and inf... |
|
|
Invention
|
Anti-cd25 antibodies.
Novel anti-human CD25 antibodies or antigen-binding fragments thereof and ... |
|
|
Invention
|
Antibodies conjugated or fused to the receptor-binding domain of the sars-cov-2 spike protein and... |
|
|
Invention
|
Use of e. coli strains expressing high level of alpha-gal to modulate immunity and provide protec... |
|
|
Invention
|
Severe acute respiratory syndrome coronavirus 2 (sars-cov-2) polypeptides and uses thereof for va... |
|
|
Invention
|
Use of psychotropic drugs for the treatment of coronavirus infections.
The coronavirus SARS-Cov-... |
|
|
Invention
|
Recombinant proteins with ox40 activating properties.
The disclosure relates to the field of OX4... |
|
|
Invention
|
Methods and compositions to determine the quality of red blood cell units.
The present invention... |
|
|
Invention
|
Alisporivir for use in human viral infections.
The present invention concerns alisporivir for us... |
|
|
Invention
|
Methods for discontinuing a treatment with a tyrosine kinase inhibitor (tki).
The present invent... |
|
2020
|
Invention
|
Method for identifying an infectious agents.
The present invention provides methods for detectin... |
|
|
Invention
|
Novel immunotherapies targeting pd-1 with anti-pd-1/il-15 immunocytokines.
The inventors now pro... |
